VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Manfred Sondermann who wrote (112)	7/20/1999 1:16:00 PM
From: Manfred Sondermann	of 250

As I have expected: I found a web side indicating, that VXGN has started in February 99 a small trial of AIDSVAX in Africa. Note that in Africa we have a different HIV subtype, so Vaxgen is here also using a different gp120 vaccine. geocities.com On Monday [Feb 8 1999], the U.S. National Institutes of Health announced the testing another possible vaccine in Uganda. The yearlong study is enrolling 40 healthy adults at low risk of getting HIV; 20 will get the experimental vaccine. Researchers in Uganda will monitor safety reactions and immune system changes to see if the vaccine has anti-HIV potential. If so, larger studies could follow.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next